Journal article

Discussions about predictive genetic testing for Lynch syndrome: the role of health professionals and families in decisions to decline

A Kanga-Parabia, C Gaff, L Flander, M Jenkins, LA Keogh

Familial Cancer | SPRINGER | Published : 2018

Abstract

Unaffected relatives of individuals with Lynch syndrome can be offered predictive genetic testing to guide surveillance recommendations. The decision-making process of those who decline testing, particularly those who do not attend a clinical genetics service, is poorly understood. We have addressed this gap by interviewing 33 individuals from Lynch syndrome mutation-carrying families, unaffected by cancer, who declined predictive genetic testing. Here, we analyse the data provided by 20 participants who unequivocally declined testing. Those who indicated they did not have enough information to make a decision or intended to undergo testing in the future were excluded. Analysis revealed that..

View full abstract

Grants

Awarded by National Institutes of Health


Funding Acknowledgements

This work was supported by the Victorian Cancer Agency (#EO109-33), National Cancer Institute, National Institutes of Health (RFA #CA-95-011), and through cooperative agreements with the Australasian Colorectal Cancer Family Registry (U01 CA097735). Findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Cancer Institute. We acknowledge the data collection conducted by Alison Rutstein and Heather Niven, and thank the participants for sharing their experiences.